Lindenwood University

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Lindenwood University sits in the top decile of US sponsors by registered trial count (#553 of 15,742 sponsors by registered trial count).

29 total trials 4 currently recruiting 22 completed top decile by trial count

Lindenwood University: 29 sponsored US clinical trials, 4 recruiting.

Lindenwood University sponsors 29 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 22 completed. The most-studied condition in this pipeline is Hypertrophy, with 2 trials.

Top-decile sponsor footprint

Lindenwood University ranks in the top decile of sponsors by registered trial count (#553 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 79/100

22 of 23 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (95.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

29 total, page 1 of 1

RECRUITING NA

A Pilot Study to Evaluate the Ability of Lactoferrin to Modulate Iron Homeostasis and Exercise Performance in Exercising Females

NCT07546591

RECRUITING NA

Impact of Weizmannia (Bacillus) Coagulans JBI-YZ6.3 on Gut Health and Fecal Microbiome Changes

NCT07388264

RECRUITING NA

Dose-Response Impact of Glucosyl-Hesperidin (CitraPeak) on Exercise Performance, Blood Flow, Stress, Cognition, and Other Perceptual Indicators

NCT06672952

RECRUITING NA

Dose-Response Impact of Geranylgeraniol (GG) Supplementation on Muscle Health

NCT07502924

NOT YET RECRUITING NA

Evaluating the Ability of a Multi-Strain Postbiotic to Impact Inflammation, Immune Components, Gastrointestinal Symptoms, Recovery, Anxiety, and Intestinal Permeability

NCT07387991

COMPLETED NA

Evaluation of Cordyceps Militaris M2-116-04 for Its Potential Sport and Exercise Nutrition Applications in Healthy Active Adults

NCT07310108

NOT YET RECRUITING NA

A Randomized, Double-Blind Study to Assess the Effect of a Postbiotic on Oxidative Stress and Exercise Performance

NCT06795425

COMPLETED NA

Exercise-Induced Rates of Fat Oxidation with and Without Ingestion of a Caffeine-Based Energy Drink

NCT06308731

COMPLETED NA

Effects of Alpha-GPC on Muscle Power, GH Levels, and Cognitive Function

NCT06690619

COMPLETED NA

A Randomized Study to Examine the Ability of a Caffeine-Based Energy Drink to Impact Energy Expenditure, Fat Oxidation, Reaction Time, and Other Perceptual Indicators

NCT05998096

COMPLETED NA

Impact of Powdered Tart Cherries on Recovery From Repeated Sprints

NCT06122038

COMPLETED NA

Effects of Adding L-BAIBA or L-BAIBA + Grains of Paradise to Exercising Adult Overweight and Obese Men and Women

NCT05775003

TERMINATED NA

Effects of Adding L-BAIBA to Exercising Adult Overweight and Obese Men and Women

NCT05775016

COMPLETED NA

Kefir Versus Milk on Time-Trial Performance in Masters Athletes

NCT06165523

COMPLETED NA

Effect of a Novel Blend of Plant Protein and Additional Ingredients on Resistance Training Adaptations

NCT06908811

COMPLETED NA

A Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of LasoperinTM on Cognitive Function in Healthy Adults

NCT05994391

COMPLETED NA

Pilot Study to Examine the Acute Impact of Veillonella Supplementation on Exercise and Lactate Responses

NCT05816291

COMPLETED NA

Changes in Metabolic Rate and Perceptual Indicators After Acute Ingestion of Paraxanthine

NCT05811923

COMPLETED NA

Dose-Response Effect of Phosphatidylserine on eSport Performance

NCT07533032

COMPLETED NA

Effects of Paraxanthine Supplementation on eSport Performancre

NCT07533045

COMPLETED NA

Dileucine and Resistance Training Adaptations

NCT06121869

COMPLETED NA

Changes in Plasma Amino Acid Appearance After Adding Bacillus Coagulans GBI-30, 6086 to Milk Protein Concentrate

NCT05313178

COMPLETED NA

A Pilot Study to Determine the Bioavailability of Oral Beta-Aminoisobutyric Acid (BAIBA) Ingestion

NCT05328271

COMPLETED NA

Effect of the Combination of Nitrate and Caffeine on Critical Power In Trained Male Cyclists

NCT07501806

COMPLETED NA

Bioavailability of Berberine and Dihydroberberine and Their Impact on Glycemia

NCT05021341

COMPLETED NA

Changes in Amino Acid Absorption After Adding a Probiotic to an Acute Protein Feeding

NCT04427020

COMPLETED NA

Probiotic Administration on Mood

NCT05343533

COMPLETED NA

Immune and Recovery Modulating Impact of Probiotic Supplementation After Intense Resistance Exercise

NCT04441840

COMPLETED NA

Effect of Daily Doses of Rice or Whey Protein on Resistance Training Adaptations

NCT04411173

What is open in the Lindenwood University pipeline

4 recruiting of 29 indexed (14% open); 22 completed (76%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Hypertrophy (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Lindenwood University: open-pipeline peers nationwide

Peers matched on 29 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

Lindenwood University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0200400600 0%20%40%60%80%100% Total trials Recruiting share Lindenwood UniversityBeOne MedicinesBioCryst PharmaceuticalsCalifornia Pacific Medical Center Research InstituteCenter for International Blood and Marrow Transplant ResearchVirginia Commonwealth UniversityBeiGeneReproductive Medicine Associates of New JerseyUniversity of Cincinnati
Lindenwood University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Lindenwood University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 29 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

What to do with this Lindenwood University page

29 registered trials is a research-attention snapshot, not an endorsement of Lindenwood University or any single study.

  • 4 of Lindenwood University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Hypertrophy is the condition Lindenwood University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertrophy trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Lindenwood University pipeline card: 29 registered trials from official public datasets.Report a data error.